Evidence map›Paper›PMID 31389988›Full record

ArticleJAMA cardiology2019

Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients With Takotsubo Syndrome.

Francesco Santoro, Iván J Núñez Gil, Thomas Stiermaier, Ibrahim El-Battrawy, Federico Guerra, Giuseppina Novo, Francesca Guastafierro, Nicola Tarantino, Salvatore Novo, Enrica Mariano and 17 more

Erratum issued 2 registry-linked trialsAbstract readMulticenter Study
In one paragraph

Article in JAMA cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05731830 recruitingnot on this mapstarted 2022, after this paper: background citation

Takotsubo Syndrome and Air Pollution: the "Tako-Air" Study

TypeobservationalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2022 to 2026Enrolled250ConditionsTakotsubo SyndromeArmsData extraction, Clinical follow-up
NCT05793008 narecruitingnot on this mapstarted 2023, after this paper: background citation

Characterization of priMary And sEcondary STress Related takOtsubo: the MAESTRO Pilot Study

TypeinterventionalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2023 to 2026Enrolled60ConditionsTakotsubo Cardiomyopathy, Sepsis-induced CardiomyopathyArmsPositron Emission Tomography (PET) analysis, Blood samples collection, Clinical follow up visit
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A novel parameter for risk stratification in patients with takotsubo syndrome.American heart journal plus : cardiology research and practice · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Prospective comparison of temporal changes in myocardial function in women with Takotsubo versus anterior STEMI.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Observational
  11. Article
  12. Validation of Takotsubo Syndrome Scoring System.Diagnostics (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Article
  15. Gender disparities in outcomes of cardiogenic shock secondary to Takotsubo cardiomyopathy.American heart journal plus : cardiology research and practice · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Francesco SantoroDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Iván J Núñez GilInterventional Cardiology, Cardiovascular Institute, Hospital Clínico Universitario San Carlos, Madrid, Spain.
Thomas StiermaierMedical Clinic II (Cardiology/Angiology/Intensive Care Medicine), University Heart Center Lübeck, Lübeck, Germany.
Ibrahim El-BattrawyFirst Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Federico GuerraCardiology and Arrhythmology Clinic, Marche Polytechnic University, University Hospital, Umberto I-Lancisi-Salesi, Ancona, Italy.
Giuseppina NovoBiomedical Department of Internal Medicine and Medical Specialties, Cardiology Unit, University of Palermo, Palermo, Italy.
Francesca GuastafierroDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Nicola TarantinoDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Salvatore NovoBiomedical Department of Internal Medicine and Medical Specialties, Cardiology Unit, University of Palermo, Palermo, Italy.
Enrica MarianoDivision of Cardiology, University of Rome Tor Vergata, Rome, Italy.
Francesco RomeoDivision of Cardiology, University of Rome Tor Vergata, Rome, Italy.
Fabiana RomeoDivision of Cardiology, University of Rome Tor Vergata, Rome, Italy.
Alessandro CapucciCardiology and Arrhythmology Clinic, Marche Polytechnic University, University Hospital, Umberto I-Lancisi-Salesi, Ancona, Italy.
Edda BahlmannDepartment of Cardiology, Asklepios Klinik-St Georg, Hamburg, Germany.
Maddalena ZingaroDepartment of Cardiology, Bonomo Hospital, Andria, Italy.
Michele CannoneDepartment of Cardiology, Bonomo Hospital, Andria, Italy.
Pasquale CaldarolaDepartment of Cardiology, San Paolo Hospital, Bari, Italy.
Maria Francesca MarchettiDepartment of Cardiology, San Giovanni di Dio Hospital, University of Cagliari, Cagliari, Italy.
Roberta MontisciDepartment of Cardiology, San Giovanni di Dio Hospital, University of Cagliari, Cagliari, Italy.
Luigi MeloniDepartment of Cardiology, San Giovanni di Dio Hospital, University of Cagliari, Cagliari, Italy.
Holger ThieleDepartment of Internal Medicine and Cardiology, Heart Center Leipzig-University Hospital, Leipzig, Germany.
Matteo Di BiaseGruppo Villa Maria Care and Research, Santa Maria Hospital, Bari, Italy.
Manuel Almendro-DeliaServicio de Cardiología, Hospital Virgen de la Macarena, Sevilla, Spain.
Alessandro SionisUnidad de Cuidados Intensivos Cardiológicos, Servicio de Cardiología, Hospital de Sant Pau, Instituto de Investigación Biomédica Sant Pau (IIB Sant Pau), Barcelona, Spain.
Ibrahim AkinFirst Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Ingo EitelMedical Clinic II (Cardiology/Angiology/Intensive Care Medicine), University Heart Center Lübeck, Lübeck, Germany.
Natale Daniele BrunettiDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Takotsubo syndrome (TTS) is an acute, reversible heart failure syndrome featured by significant rates of in-hospital complications. There is a lack of data for risk stratification during hospitalization. Objective: To derive a simple clinical score for risk prediction of in-hospital complications among patients with TTS. Design, Setting, and Participants: In this prognostic study, 1007 consecutive patients were enrolled in the German and Italian Stress Cardiomyopathy (GEIST) registry from July 1, 2007, through December 31, 2017, and identified as the derivation cohort; 946 patients were enrolled in the Spanish Registry for Takotsubo Cardiomyopathy (RETAKO) as the external score validation. An admission risk score was developed using a stepwise multivariable regression analysis from 2 registries. Data analysis was performed from March 1, 2018, through July 31, 2018. Main Outcomes and Measures: In-hospital complications were defined as death, pulmonary edema, need for invasive ventilation, and cardiogenic shock. Four variables were identified as independent predictors of in-hospital complications and were used for the score: male sex, history of neurologic disorder, right ventricular involvement, and left ventricular ejection fraction (LVEF). Results: Of the 1007 patients enrolled in the GEIST registry, 107 (10.6%) were male, with mean (SD) age of 69.8 (11.4) years. Overall rate of in-hospital complications was 23.3% (235 of 1007) (death, 4.0%; pulmonary edema, 5.8%; invasive ventilation, 6.4%; and cardiogenic shock, 9.1%). The GEIST prognosis score was derived by providing 20 points each for male sex and history of neurologic disorders and 30 points for right ventricular involvement and then subtracting the value in percent of LVEF (decimal values between 0.15 and 0.70). Score accuracy on area under the receiver operating characteristic curve analysis was 0.71, with a negative predictive power of 87% with scores less than 20. External validation in the RETAKO population (124 [13.1%] male; mean [SD] age, 69.5 [14.9] years) revealed an area under the curve of 0.73 (P = .46 vs GEIST derivation cohort). Stratification into 3 risk groups (<20, 20-40, and >40 points) classified 316 patients (40.9%) as having low risk; 342 (44.3%) as having intermediate risk, and 114 (14.8%) as having high risk of complications. The observed in-hospital complication rates were 12.7% for low-risk patients, 23.4% for intermediate-risk patients, and 58.8% for high-risk patients (P < .001 for trend). After 2.6 years of follow-up, patients with in-hospital complications had significantly higher rates of mortality than those without complications (40% vs 10%, P = .01). Conclusions and Relevance: The GEIST prognostic score may be useful in early risk stratification for TTS. High-risk patients with TTS may require an intensive care unit stay, and low-risk patients with TTS could be discharged within a few days. In-hospital complications in patients with TTS may be associated with increased risk of long-term mortality.

Indexed as

InpatientsRegistriesAgedEchocardiographyFemaleGermanyHeart FailureHumansIncidenceItalyMalePrognosisRisk AssessmentRisk FactorsROC CurveStroke Volume

Identifiers

PMID31389988
PMCPMC6686773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.